img

Global Canine Arthritis Therapeutics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Canine Arthritis Therapeutics Market Insights, Forecast to 2034

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. 
Market Analysis and InsightsGlobal Canine Arthritis Therapeutics Market
Global Canine Arthritis Therapeutics market is expected to reach to US$ 2489 million in 2024, with a positive growth of %, compared with US$ 2391 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Canine Arthritis Therapeutics industry is evaluated to reach US$ 3185.9 million in 2029. The CAGR will be 4.2% during 2024 to 2029.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
Report Covers
This report presents an overview of global Canine Arthritis Therapeutics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Canine Arthritis Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Elanco
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy

Segment by Application


Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Canine Arthritis Therapeutics introduction, etc. Canine Arthritis Therapeutics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Canine Arthritis Therapeutics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.2.4 Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Canine Arthritis Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Arthritis Therapeutics Market Perspective (2018-2029)
2.2 Global Canine Arthritis Therapeutics Growth Trends by Region
2.2.1 Canine Arthritis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Canine Arthritis Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 Canine Arthritis Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Canine Arthritis Therapeutics Market Dynamics
2.3.1 Canine Arthritis Therapeutics Industry Trends
2.3.2 Canine Arthritis Therapeutics Market Drivers
2.3.3 Canine Arthritis Therapeutics Market Challenges
2.3.4 Canine Arthritis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Canine Arthritis Therapeutics by Players
3.1.1 Global Canine Arthritis Therapeutics Revenue by Players (2018-2024)
3.1.2 Global Canine Arthritis Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global Canine Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Canine Arthritis Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Canine Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Canine Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Therapeutics Revenue in 2022
3.5 Global Key Players of Canine Arthritis Therapeutics Head office and Area Served
3.6 Global Key Players of Canine Arthritis Therapeutics, Product and Application
3.7 Global Key Players of Canine Arthritis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Arthritis Therapeutics Breakdown Data by Type
4.1 Global Canine Arthritis Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2024-2029)
5 Canine Arthritis Therapeutics Breakdown Data by Application
5.1 Global Canine Arthritis Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Canine Arthritis Therapeutics Market Size (2018-2029)
6.2 North America Canine Arthritis Therapeutics Market Size by Type
6.2.1 North America Canine Arthritis Therapeutics Market Size by Type (2018-2024)
6.2.2 North America Canine Arthritis Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Canine Arthritis Therapeutics Market Share by Type (2018-2029)
6.3 North America Canine Arthritis Therapeutics Market Size by Application
6.3.1 North America Canine Arthritis Therapeutics Market Size by Application (2018-2024)
6.3.2 North America Canine Arthritis Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Canine Arthritis Therapeutics Market Share by Application (2018-2029)
6.4 North America Canine Arthritis Therapeutics Market Size by Country
6.4.1 North America Canine Arthritis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Canine Arthritis Therapeutics Market Size by Country (2018-2024)
6.4.3 North America Canine Arthritis Therapeutics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Canine Arthritis Therapeutics Market Size (2018-2029)
7.2 Europe Canine Arthritis Therapeutics Market Size by Type
7.2.1 Europe Canine Arthritis Therapeutics Market Size by Type (2018-2024)
7.2.2 Europe Canine Arthritis Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Canine Arthritis Therapeutics Market Share by Type (2018-2029)
7.3 Europe Canine Arthritis Therapeutics Market Size by Application
7.3.1 Europe Canine Arthritis Therapeutics Market Size by Application (2018-2024)
7.3.2 Europe Canine Arthritis Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Canine Arthritis Therapeutics Market Share by Application (2018-2029)
7.4 Europe Canine Arthritis Therapeutics Market Size by Country
7.4.1 Europe Canine Arthritis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Canine Arthritis Therapeutics Market Size by Country (2018-2024)
7.4.3 Europe Canine Arthritis Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Canine Arthritis Therapeutics Market Size (2018-2029)
8.2 China Canine Arthritis Therapeutics Market Size by Type
8.2.1 China Canine Arthritis Therapeutics Market Size by Type (2018-2024)
8.2.2 China Canine Arthritis Therapeutics Market Size by Type (2024-2029)
8.2.3 China Canine Arthritis Therapeutics Market Share by Type (2018-2029)
8.3 China Canine Arthritis Therapeutics Market Size by Application
8.3.1 China Canine Arthritis Therapeutics Market Size by Application (2018-2024)
8.3.2 China Canine Arthritis Therapeutics Market Size by Application (2024-2029)
8.3.3 China Canine Arthritis Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Canine Arthritis Therapeutics Market Size (2018-2029)
9.2 Asia Canine Arthritis Therapeutics Market Size by Type
9.2.1 Asia Canine Arthritis Therapeutics Market Size by Type (2018-2024)
9.2.2 Asia Canine Arthritis Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Canine Arthritis Therapeutics Market Share by Type (2018-2029)
9.3 Asia Canine Arthritis Therapeutics Market Size by Application
9.3.1 Asia Canine Arthritis Therapeutics Market Size by Application (2018-2024)
9.3.2 Asia Canine Arthritis Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Canine Arthritis Therapeutics Market Share by Application (2018-2029)
9.4 Asia Canine Arthritis Therapeutics Market Size by Region
9.4.1 Asia Canine Arthritis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Canine Arthritis Therapeutics Market Size by Region (2018-2024)
9.4.3 Asia Canine Arthritis Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Canine Arthritis Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Zoetis Inc
11.2.1 Zoetis Inc Company Details
11.2.2 Zoetis Inc Business Overview
11.2.3 Zoetis Inc Canine Arthritis Therapeutics Introduction
11.2.4 Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.2.5 Zoetis Inc Recent Developments
11.3 Vetoquinol S.A.
11.3.1 Vetoquinol S.A. Company Details
11.3.2 Vetoquinol S.A. Business Overview
11.3.3 Vetoquinol S.A. Canine Arthritis Therapeutics Introduction
11.3.4 Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.3.5 Vetoquinol S.A. Recent Developments
11.4 Elanco
11.4.1 Elanco Company Details
11.4.2 Elanco Business Overview
11.4.3 Elanco Canine Arthritis Therapeutics Introduction
11.4.4 Elanco Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.4.5 Elanco Recent Developments
11.5 Aratana Therapeutics Inc
11.5.1 Aratana Therapeutics Inc Company Details
11.5.2 Aratana Therapeutics Inc Business Overview
11.5.3 Aratana Therapeutics Inc Canine Arthritis Therapeutics Introduction
11.5.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.5.5 Aratana Therapeutics Inc Recent Developments
11.6 Norbrook Laboratories Limited
11.6.1 Norbrook Laboratories Limited Company Details
11.6.2 Norbrook Laboratories Limited Business Overview
11.6.3 Norbrook Laboratories Limited Canine Arthritis Therapeutics Introduction
11.6.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.6.5 Norbrook Laboratories Limited Recent Developments
11.7 VetStem Biopharma
11.7.1 VetStem Biopharma Company Details
11.7.2 VetStem Biopharma Business Overview
11.7.3 VetStem Biopharma Canine Arthritis Therapeutics Introduction
11.7.4 VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.7.5 VetStem Biopharma Recent Developments
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Company Details
11.8.2 Dechra Pharmaceuticals Plc Business Overview
11.8.3 Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Introduction
11.8.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2018-2024)
11.8.5 Dechra Pharmaceuticals Plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Canine Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Opioids
Table 4. Key Players of Stem Cell Therapy
Table 5. Global Canine Arthritis Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Canine Arthritis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Canine Arthritis Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Canine Arthritis Therapeutics Market Share by Region (2018-2024)
Table 9. Global Canine Arthritis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Canine Arthritis Therapeutics Market Share by Region (2024-2029)
Table 11. Canine Arthritis Therapeutics Market Trends
Table 12. Canine Arthritis Therapeutics Market Drivers
Table 13. Canine Arthritis Therapeutics Market Challenges
Table 14. Canine Arthritis Therapeutics Market Restraints
Table 15. Global Canine Arthritis Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Canine Arthritis Therapeutics Revenue Share by Players (2018-2024)
Table 17. Global Top Canine Arthritis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Therapeutics as of 2022)
Table 18. Global Canine Arthritis Therapeutics Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Canine Arthritis Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Canine Arthritis Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Canine Arthritis Therapeutics, Product and Application
Table 22. Global Key Players of Canine Arthritis Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Canine Arthritis Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2018-2024)
Table 26. Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global Canine Arthritis Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Canine Arthritis Therapeutics Revenue Share by Application (2018-2024)
Table 30. Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Canine Arthritis Therapeutics Revenue Share by Application (2024-2029)
Table 32. North America Canine Arthritis Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Canine Arthritis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Canine Arthritis Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Canine Arthritis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Canine Arthritis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Canine Arthritis Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Canine Arthritis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Canine Arthritis Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Canine Arthritis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Canine Arthritis Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Canine Arthritis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Canine Arthritis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Canine Arthritis Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Canine Arthritis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Canine Arthritis Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Canine Arthritis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Canine Arthritis Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Canine Arthritis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Canine Arthritis Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Canine Arthritis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Canine Arthritis Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Canine Arthritis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Canine Arthritis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Canine Arthritis Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Canine Arthritis Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 64. Boehringer Ingelheim Company Details
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim Canine Arthritis Therapeutics Product
Table 67. Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 68. Boehringer Ingelheim Recent Developments
Table 69. Zoetis Inc Company Details
Table 70. Zoetis Inc Business Overview
Table 71. Zoetis Inc Canine Arthritis Therapeutics Product
Table 72. Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 73. Zoetis Inc Recent Developments
Table 74. Vetoquinol S.A. Company Details
Table 75. Vetoquinol S.A. Business Overview
Table 76. Vetoquinol S.A. Canine Arthritis Therapeutics Product
Table 77. Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 78. Vetoquinol S.A. Recent Developments
Table 79. Elanco Company Details
Table 80. Elanco Business Overview
Table 81. Elanco Canine Arthritis Therapeutics Product
Table 82. Elanco Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 83. Elanco Recent Developments
Table 84. Aratana Therapeutics Inc Company Details
Table 85. Aratana Therapeutics Inc Business Overview
Table 86. Aratana Therapeutics Inc Canine Arthritis Therapeutics Product
Table 87. Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 88. Aratana Therapeutics Inc Recent Developments
Table 89. Norbrook Laboratories Limited Company Details
Table 90. Norbrook Laboratories Limited Business Overview
Table 91. Norbrook Laboratories Limited Canine Arthritis Therapeutics Product
Table 92. Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 93. Norbrook Laboratories Limited Recent Developments
Table 94. VetStem Biopharma Company Details
Table 95. VetStem Biopharma Business Overview
Table 96. VetStem Biopharma Canine Arthritis Therapeutics Product
Table 97. VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 98. VetStem Biopharma Recent Developments
Table 99. Dechra Pharmaceuticals Plc Company Details
Table 100. Dechra Pharmaceuticals Plc Business Overview
Table 101. Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Product
Table 102. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2018-2024) & (US$ Million)
Table 103. Dechra Pharmaceuticals Plc Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Arthritis Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Canine Arthritis Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 4. Opioids Features
Figure 5. Stem Cell Therapy Features
Figure 6. Global Canine Arthritis Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Canine Arthritis Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Veterinary Hospitals and Clinics Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Canine Arthritis Therapeutics Report Years Considered
Figure 12. Global Canine Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Canine Arthritis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Canine Arthritis Therapeutics Market Share by Region: 2022 VS 2029
Figure 15. Global Canine Arthritis Therapeutics Market Share by Players in 2022
Figure 16. Global Top Canine Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Canine Arthritis Therapeutics Revenue in 2022
Figure 18. North America Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Canine Arthritis Therapeutics Market Share by Type (2018-2029)
Figure 20. North America Canine Arthritis Therapeutics Market Share by Application (2018-2029)
Figure 21. North America Canine Arthritis Therapeutics Market Share by Country (2018-2029)
Figure 22. United States Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Canine Arthritis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Canine Arthritis Therapeutics Market Share by Type (2018-2029)
Figure 26. Europe Canine Arthritis Therapeutics Market Share by Application (2018-2029)
Figure 27. Europe Canine Arthritis Therapeutics Market Share by Country (2018-2029)
Figure 28. Germany Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Canine Arthritis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Canine Arthritis Therapeutics Market Share by Type (2018-2029)
Figure 36. China Canine Arthritis Therapeutics Market Share by Application (2018-2029)
Figure 37. Asia Canine Arthritis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Canine Arthritis Therapeutics Market Share by Type (2018-2029)
Figure 39. Asia Canine Arthritis Therapeutics Market Share by Application (2018-2029)
Figure 40. Asia Canine Arthritis Therapeutics Market Share by Region (2018-2029)
Figure 41. Japan Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Canine Arthritis Therapeutics Market Share by Country (2018-2029)
Figure 51. Brazil Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Canine Arthritis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 58. Zoetis Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 59. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 60. Elanco Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 61. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 62. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 63. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 64. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed